Home>News & Events>Events>QuantMed

News & Events

  • October 6, 2023

    Innovative Trial Design Approaches to Model Informed Drug Development in Rare and Neurological Diseases

     Are you passionate about making a difference in the fields of neurology and rare diseases? Do you want to explore new methods that can revolutionize drug development in these critical areas? Join us for an enlightening webinar where we’ll delve into the latest advancements and strategies. Oct. 6, 2023 | 11 AM ET Gain an......
  • June 25, 2023 - June 29, 2023

    DIA 2023 Global Annual Meeting | ILLUMINATE

     The DIA 2023 Global Annual Meeting invites industry, regulatory government, academics, and patients to network, problem-solve, and discuss global and local challenges facing the life sciences community. Hosted in Boston, key C-Path personnel will be on-hand to discuss and view the many different perspectives offered at this event, while highlights expertise across the globe to......
  • September 17, 2020

    How Math, Statistics, and Artificial Intelligence Can be Used to Develop Treatments for Major Diseases: Quantitative Medicine at the Critical Path Institute

    This presentation focuses on the bridge between a person’s ultimate health in light of being affected by a debilitating disease, and how a novel treatment for that disease can be back-tracked to the use of quantitative methods to help guide the development of such novel treatments. Case studies in multiple diseases including, Alzheimer’s, Parkinson’s, type-1 diabetes and polycystic kidney disease will be shown to demonstrate the process.

    Presenter: Jackson Burton, PhD, Executive Director, C-Path Quantitative Medicine Program

    Part of Arizona Bioscience Week Educational Events | Register for AZBW 2020

Refine:

Period

Program

  • All Programs
  • T1D - Type 1 Diabetes Consortium
  • RegSci - Regulatory Science Program
  • CPA-1 - Critical Path for Alpha-1 Antitrypsin Deficiency
  • CPLD - Critical Path for Lysosomal Diseases Consortium
  • CP-RND - Critical Path for Rare Neurodegenerative Diseases
  • TRxA - Translational Therapeutics Accelerator
  • RD-COA Consortium - Rare Disease Clinical Outcome Assessment Consortium
  • CPTA - Critical Path to Therapeutics for the Ataxias
  • PredicTox KE - PredicTox Knowledge Environment
  • CP-SCD - Critical Path for Sickle Cell Disease
  • CDRC - CURE Drug Repurposing Collaboratory
  • QuantMed - Quantitative Medicine Program
  • TOMI-T1D - Trial Outcome Markers Initiative in T1D
  • RDCA-DAP - Rare Disease Cures Accelerator-Data and Analytics Platform
  • HD-RSC - Huntington’s Disease Regulatory Science Consortium
  • CPAD - Critical Path for Alzheimer's Disease
  • TTC - Transplant Therapeutics Consortium
  • BmDR - Biomarker Data Repository
  • CFAST - Coalition For Accelerating Standards and Therapies
  • CPP - Critical Path for Parkinson's
  • CPTR - Critical Path to TB Drug Regimens
  • DCC - Data Collaboration Center
  • D-RSC - Duchenne Regulatory Science Consortium
  • INC - International Neonatal Consortium
  • MSOAC - Multiple Sclerosis Outcome Assessments Consortium
  • PKD - Polycystic Kidney Disease Outcomes Consortium
  • PRO Consortium - Patient-Reported Outcome Consortium
  • eCOA Consortium - Electronic Clinical Outcome Assessment Consortium
  • PSTC - Predictive Safety Testing Consortium
  • PTC - Pediatric Trials Consortium
  • TB-PACTS - TB-Platform for Aggregation of Clinical TB Studies

Category

Tags

x